DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAGP

Scabies diagnosis and contact treatment

Essential points for quick revision.

Synopsis

Recognise ordinary and crusted scabies, confirm uncertain disease, treat the whole skin field correctly, coordinate simultaneous close-contact treatment and distinguish persistent post-scabetic itch from failure.

  • Suspect scabies with new intense nocturnal itch, affected close contacts, burrows and papules at finger webs, wrists, axillae, waist, buttocks, genitalia or areolae.
  • In infants, older people and immune compromise, scalp, face, palms and soles may be involved; crusted scabies can itch little despite huge mite burden.
  • Apply permethrin 5% cream to the complete recommended skin field, including under nails and between digits, leave 8–12 hours and repeat after seven days.

Key red flags

Crusted scabies, institutional outbreak, secondary sepsis, pregnancy or infancy with treatment uncertainty, severe immune or neurological impairment, eye exposure or persistent disease after correctly coordinated courses requires specialist or UKHSA support.

Crusted scabies

Extensive hyperkeratotic scale, fissures and nail debris in a vulnerable host indicates highly infectious hyperinfestation.

Investigation priorities

01
Dermoscopy of a burrowFirst step

Visualise a mite and guide scraping in uncertain disease.

Management branches

Ordinary scabiesTreat patient and contacts together

Typical itch, distribution or confirmed mites occurs without crusted disease.

  1. Apply permethrin 5% to the complete age-appropriate skin field for 8–12 hours, reapplying washed hands.
  2. Repeat after seven days and treat household and sexual contacts on both dates regardless of symptoms.

Key medicines

Permethrin 5% creamApply to the entire recommended skin surface, leave for 8–12 hours, wash off and repeat the complete application after seven days.
Open full textbook Answer 2 questions
Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom